Related Experiment Video
Updated: Jan 6, 2026
08:45
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
14.0K
Simvastatin improves lysosome function via enhancing lysosome biogenesis in endothelial cells
Youzhi Zhang1, Yun-Ting Wang2, Saisudha Koka2
1School of Pharmacy, Hubei University of Science and Technology, Xianning, China.
Frontiers in Bioscience (Landmark Edition)
|October 6, 2019
Summary
Simvastatin prevents obesity-related endothelial dysfunction by improving lysosome function, blocking NLRP3 inflammasome activation, and reducing hyperpermeability. This highlights a key mechanism for statin cardiovascular benefits.
Area of Science:
- Cardiovascular Science
- Cell Biology
- Metabolic Disease Research
Background:
- Obesity is linked to cardiovascular complications, including endothelial barrier dysfunction and hyperpermeability, partly mediated by NLRP3 inflammasomes.
- Statins are known to reduce cardiovascular risk in obese and diabetic patients, but their specific effects on obesity-induced endothelial dysfunction via NLRP3 inflammasome pathways are not fully understood.
Purpose of the Study:
- To investigate whether simvastatin treatment ameliorates obesity-induced endothelial barrier dysfunction by blocking the NLRP3 inflammasome signaling axis.
- To elucidate the underlying mechanisms by which simvastatin exerts its protective effects on endothelial cells.
Main Methods:
- Utilized mouse microvascular endothelial cells (MVECs) exposed to free fatty acids to model obesity-induced endothelial dysfunction.
- Assessed the effects of simvastatin on endothelial hyperpermeability, ZO-1 and VE-cadherin junction integrity, and lysosome function.
- Investigated the role of autophagy and lysosome biogenesis in simvastatin's protective mechanism against NLRP3 inflammasome activation.
Main Results:
- Simvastatin effectively prevented free fatty acid-induced endothelial hyperpermeability and disruption of endothelial cell junctions (ZO-1 and VE-cadherin).
- The protective effect was attributed to simvastatin's ability to improve lysosome function, thereby attenuating NLRP3 inflammasome activation and HMGB1 release.
- Simvastatin was found to induce autophagy, facilitating the clearance of damaged lysosomes and promoting lysosome regeneration.
Conclusions:
- Simvastatin treatment improves endothelial barrier function in obesity by enhancing lysosome function through increased biogenesis and autophagic turnover.
- This improvement in lysosome function suppresses NLRP3 inflammasome activation, offering a potential therapeutic mechanism for preventing obesity-associated endothelial hyperpermeability and cardiovascular complications.
More Related Videos
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
01:31Lysosomes
25.2K
Lysosomes are membrane-enclosed spherical sacs derived from the Golgi apparatus. The most important function of the lysosome is degrading macromolecules and biological polymers that are released during membrane trafficking events such as the secretory, endocytic, autophagic, and phagocytic pathways. The degradation is carried out by several hydrolytic enzymes active in an acidic environment of the lysosomal lumen. These acid hydrolases are involved in cellular processes such as cell signaling,...
25.2K
01:22Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
01:24Lipid Absorption
2.4K
Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
2.4K
01:06Lipid Digestion
98.4K
Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.
98.4K
01:38Intralumenal Vesicles and Multivesicular Bodies
4.6K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
4.6K